% Expired Patents = 75.0

EPO Patents = 3

Forward Citations = 21

Loading Chart...

10 inventors (with patents filed for the assignee):

Tuuli Ranki (3 out of 3 patents)

Sari Anneli Pesonen (3 out of 3 patents)

Vincenzo Cerullo (2 out of 11 patents)

4. Magnus Jäderberg (2 out of 2 patents)

5. Elina Haavisto (2 out of 2 patents)

6. Lukasz Kuryk (2 out of 2 patents)

7. Antti Vuolanto (2 out of 2 patents)

8. Akseli Hemminki (2 out of 7 patents)

9. Anniina Koski (1 out of 1 patent)

10. Anna Kanerva (1 out of 1 patent)

11. Lotta Vassilev (0 patent)

12. Sari Pesonen (2 patents)

4 patents: Sort by Forward Citations

1. 11690913 - Combining adenovirus and checkpoint inhibitors for treating cancer (2023-07-04),

2. 10940203 - Combining adenovirus and checkpoint inhibitors for treating cancer (2021-03-09),

3. 9410129 - Recombinant serotype 5 (Ad5) adenoviral vectors (2016-08-09),

4. 9345787 - Adenoviral vectors and methods and uses related thereto (2016-05-24),

Company Overview

Targovax is a clinical-stage immuno-oncology company focused on developing therapies to harness the patient's immune system to fight cancer. The company's pipeline includes several therapeutic cancer vaccines and oncolytic viruses. Targovax aims to bring innovative treatment options to cancer patients in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#114 in Espoo

#642 in Finland

Espoo, Finland

Targovax Oy

Forward Citations = 21

10 inventors:

Tuuli Ranki (3 out of 3 patents)

Sari Anneli Pesonen (3 out of 3 patents)

Vincenzo Cerullo (2 out of 11 patents)

4. Magnus Jäderberg (2 out of 2 patents)

5. Elina Haavisto (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Targovax Oy. Retrieved from https://idiyas.com/company/targovax-oy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]